High prevalence of occult left heart disease in scleroderma-pulmonary hypertension.

نویسندگان

  • Benjamin D Fox
  • Avi Shimony
  • David Langleben
  • Andrew Hirsch
  • Lawrence Rudski
  • Robert Schlesinger
  • Mark J Eisenberg
  • Dominique Joyal
  • Marie Hudson
  • Kim Boutet
  • Alexandrina Serban
  • Ariel Masetto
  • Murray Baron
چکیده

Our study aimed to determine the prevalence of occult left-heart disease in patients with scleroderma and pulmonary hypertension. In patients with pulmonary hypertension (mean pulmonary artery pressure (mean PAP)≥25 mmHg), differentiation between pre- and post-capillary pulmonary hypertension has been made according to pulmonary artery wedge pressure (PAWP) less than or more than 15 mmHg, respectively. We performed a retrospective chart review of 107 scleroderma patients. All patients with suspected pulmonary hypertension had routine right or left heart catheterisation with left ventricular end-diastolic pressure (LVEDP) measurement pre-/post-fluid challenge. We extracted demographic, haemodynamic and echocardiographic data. Patients were classified into one of four groups: haemodynamically normal (mean PAP<25 mmHg); pulmonary venous hypertension (PVH) (mean PAP≥25 mmHg, PAWP>15 mmHg); occult PVH (mean PAP≥25 mmHg, PAWP≤15 mmHg, LVEDP>15 mmHg before or after fluid challenge); and pulmonary arterial hypertension (PAH) (mean PAP≥25 mmHg, PAWP≤15 mmHg and LVEDP≤15 mmHg before or after fluid challenge). 53 out of 107 patients had pulmonary hypertension. Based on the PAWP-based definition, 29 out of 53 had PAH and 24 out of 53 had PVH. After considering the resting and post-fluid-challenge LVEDP, 11 PAH patients were reclassified as occult PVH. The occult PVH group was haemodynamically, echocardiographically and demographically closer to the PVH group than the PAH group. PVH had high prevalence in our scleroderma-pulmonary hypertension population. Distinguishing PAH from PVH with only PAWP may result in some PVH patients being misclassified as having PAH.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

HIGH PREVALENCE OF OCCULT LEFT HEART DISEASE IN SCLERODERMA- PULMONARY HYPERTENSION Running Head: Occult pulmonary venous hypertension in scleroderma

Question: What is the prevalence of occult left-heart disease in patients with scleroderma (SCL) and pulmonary hypertension (PH)? In patients with PH (mean pulmonary artery pressure mPAP≥25mmHg), differentiation between pre/post capillary PH has been made according to pulmonary artery wedge pressure (PAWP) less/more than15mmHg, respectively. Patients and Methods: Retrospective chart review of 1...

متن کامل

The prevalence of right to left shunt in chronic obstructive pulmonary disease patients with increased pulmonary hypertension

Background: One of the important etiologies for cryptogenic stroke is paradoxical embolization secondary to Patent Foramen Ovale (PFO). Foramen ovale can secondarily reopen due to Pulmonary Arterial Hypertension (PAH) which is common among the older age. PAH is known as a frequent and life threatening complication of COPD. The aim of this study was to determine the prevalence of PFO between COP...

متن کامل

The Relationship between Serum Pro‐Brain Natriuretic Peptide (Pro‐BNP) Levels and Pulmonary Arterial Hypertension (PAH) in Patients with Limited Scleroderma

Introduction: Pulmonary arterial hypertension (PAH) is a late progressive sclerodermarelated complication, which can lead to right heart failure and cor pulmonale. Given that cardiac catheterization is a diagnostic method of choice for PAH, and considering the high risks of this method, the purpose of this study was to evaluate the relationship between serum Pro‐Brain natriuretic peptide (Pro‐B...

متن کامل

Does left heart disease cause most systemic sclerosis associated pulmonary hypertension?

In this issue of the European Respiratory Journal, FOX et al. [1] present data that suggest most pulmonary hypertension (PH) in systemic sclerosis is post-capillary and that many patients are receiving pulmonary vasodilator therapy inappropriately. Of 53 patients identified as having PH, nearly half (24) had elevated wedge pressures, a further five had elevated left ventricular end-diastolic pr...

متن کامل

Sarcoidosis-Associated Pulmonary Hypertension: Diagnosis and Treatment

Peter J. Engel, MD The Christ Hospital Cincinnati, OH Sarcoidosis-associated pulmonary hypertension (SAPH) has been reported in 10% of all sarcoidosis patients. In the United States, the prevalence is similar to that reported for scleroderma. There are several possible mechanisms for SAPH, including vascular compression, granulomatous angiitis, left ventricular (LV) dysfunction, and fibrosis of...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • The European respiratory journal

دوره 42 4  شماره 

صفحات  -

تاریخ انتشار 2013